These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 18388116

  • 1. Pioglitazone attenuates diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Ko GJ, Kang YS, Han SY, Lee MH, Song HK, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2750-60. PubMed ID: 18388116
    [Abstract] [Full Text] [Related]

  • 2. Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats.
    Han SY, Kim CH, Kim HS, Jee YH, Song HK, Lee MH, Han KH, Kim HK, Kang YS, Han JY, Kim YS, Cha DR.
    J Am Soc Nephrol; 2006 May; 17(5):1362-72. PubMed ID: 16571782
    [Abstract] [Full Text] [Related]

  • 3. Rosiglitazone prevents advanced glycation end products-induced renal toxicity likely through suppression of plasminogen activator inhibitor-1.
    Yu X, Li C, Li X, Cai L.
    Toxicol Sci; 2007 Apr; 96(2):346-56. PubMed ID: 17264099
    [Abstract] [Full Text] [Related]

  • 4. Thiazolidinediones ameliorate diabetic nephropathy via cell cycle-dependent mechanisms.
    Okada T, Wada J, Hida K, Eguchi J, Hashimoto I, Baba M, Yasuhara A, Shikata K, Makino H.
    Diabetes; 2006 Jun; 55(6):1666-77. PubMed ID: 16731829
    [Abstract] [Full Text] [Related]

  • 5. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity.
    Rudofsky G, Reismann P, Grafe IA, Konrade I, Djuric Z, Tafel J, Buchbinder S, Zorn M, Humpert PM, Hamann A, Morcos M, Nawroth PP, Bierhaus A.
    Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974
    [Abstract] [Full Text] [Related]

  • 6. The direct antioxidative and anti-inflammatory effects of peroxisome proliferator-activated receptors ligands are associated with the inhibition of angiotensin converting enzyme expression in streptozotocin-induced diabetic rat aorta.
    Toba H, Miki S, Shimizu T, Yoshimura A, Inoue R, Sawai N, Tsukamoto R, Murakami M, Morita Y, Nakayama Y, Kobara M, Nakata T.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):124-32. PubMed ID: 16979161
    [Abstract] [Full Text] [Related]

  • 7. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y.
    Nephrol Dial Transplant; 2006 Mar 07; 21(3):605-15. PubMed ID: 16282336
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2009 Jan 07; 24(1):73-84. PubMed ID: 18682491
    [Abstract] [Full Text] [Related]

  • 11. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T, Takamura T, Kurita S, Matsuzawa N, Kita Y, Uno M, Akahori H, Misu H, Sakurai M, Zen Y, Nakanuma Y, Kaneko S.
    Gastroenterology; 2007 Jan 07; 132(1):282-93. PubMed ID: 17241878
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y.
    J Diabetes Complications; 2009 Jan 07; 23(2):124-9. PubMed ID: 18413206
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.
    Ohga S, Shikata K, Yozai K, Okada S, Ogawa D, Usui H, Wada J, Shikata Y, Makino H.
    Am J Physiol Renal Physiol; 2007 Apr 07; 292(4):F1141-50. PubMed ID: 17190910
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone, a specific ligand of the peroxisome proliferator-activated receptor gamma reduces gastric mucosal injury induced by ischaemia/ reperfusion in rat.
    Konturek PC, Brzozowski T, Kania J, Kukharsky V, Bazela K, Kwiecien S, Harsch I, Konturek SJ, Hahn EG.
    Scand J Gastroenterol; 2003 May 07; 38(5):468-76. PubMed ID: 12795455
    [Abstract] [Full Text] [Related]

  • 18. Improvement of inflammatory responses associated with NF-kappa B pathway in kidneys from diabetic rats.
    Chen L, Zhang J, Zhang Y, Wang Y, Wang B.
    Inflamm Res; 2008 May 07; 57(5):199-204. PubMed ID: 18465086
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 07; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 20. Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy.
    Wang JJ, Zhang SX, Mott R, Chen Y, Knapp RR, Cao W, Ma JX.
    Am J Physiol Renal Physiol; 2008 May 07; 294(5):F1166-73. PubMed ID: 18322021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.